Genotype-phenotype correlations will become evident over time, as more cases are reported, but SLC12A5 gene dosage (recessive versus dominant disorders), mutation type and the effect of mutations on protein activity may indeed influence epilepsy phenotype, including age of disease onset and clinical severity. The gene discussed is SLC12A5; the disease is epilepsy.